Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Lan CY, Wang Y, Xiong Y, et al. Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study. Lancet Oncol. 2018;19(9):1239–1246. doi:10.1016/S1470-2045(18)30349-830082170
   PubMed Web of Science ®Google Scholar
• Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019. doi:10.3322/caac.21559
   PubMed Web of Science ®Google Scholar
• Ma M, Wang J, Hu Y, Weng M, Liu X, Wang Y. Prognostic value of inflammatory biomarkers in gastric cancer patients and the construction of a predictive model. Dig Surg. 2018;1–10. doi:10.1159/000493432
   Web of Science ®Google Scholar
• Zhang LX, Wei ZJ, Xu AM, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg. 2018;56:320–327. doi:10.1016/j.ijsu.2018.06.03729969732
   PubMed Web of Science ®Google Scholar
• Lin GN, Peng JW, Liu DY, Xiao JJ, Chen YQ, Chen XQ. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy. Tumour Biol. 2014;35(11):10849–10854. doi:10.1007/s13277-014-2362-625081376
   PubMedGoogle Scholar
• Liu Y, Chen S, Zheng C, et al. The prognostic value of the preoperative C-reactive protein/albumin ratio in ovarian cancer. BMC Cancer. 2017;17(1):285. doi:10.1186/s12885-017-3220-x28431566
   PubMed Web of Science ®Google Scholar
• Zhang M, Huang XZ, Song YX, Gao P, Sun JX, Wang ZN. High platelet-to-lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with breast cancer: a meta-analysis. Biomed Res Int. 2017;2017:9503025. doi:10.1155/2017/950302529082257
   PubMed Web of Science ®Google Scholar
• Luo Y, Kim HS, Kim M, Lee M, Song YS. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. J Gynecol Oncol. 2017;28(3):e36. doi:10.3802/jgo.2017.28.e3628382799
   PubMed Web of Science ®Google Scholar
• Shehata AMF, Aldesoky AI, Gohar SF. Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma. Hematology. 2019;24(1):103–107. doi:10.1080/10245332.2018.151993230198830
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang W, Que Y, et al. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma. BMC Cancer. 2018;18(1):942. doi:10.1186/s12885-018-4242-830285656
   PubMedGoogle Scholar
• Marchetti C, Romito A, Musella A, et al. Combined plasma fibrinogen and neutrophil lymphocyte ratio in ovarian cancer prognosis may play a role? Int J Gynecol Cancer. 2018;28(5):939–944. doi:10.1097/IGC.000000000000123329538251
   PubMed Web of Science ®Google Scholar
• Muller C, Stift A, Argeny S, et al. Delta albumin is a better prognostic marker for complications following laparoscopic intestinal resection for Crohn’s disease than albumin alone – a retrospective cohort study. PLoS One. 2018;13(11):e0206911. doi:10.1371/journal.pone.020691130422980
   PubMed Web of Science ®Google Scholar
• Li C, Zhang XY, Peng W, et al. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection. Medicine (Baltimore). 2018;97(29):e11599. doi:10.1097/MD.000000000001159930024565
   PubMed Web of Science ®Google Scholar
• Huang QX, Ma J, Wang YS. Significance of preoperative ischemia- modified albumin in operable and advanced gastric cancer. Cancer Biomark. 2018;22(3):477–485. doi:10.3233/CBM-17109029843211
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Saito H, Uejima C, et al. Combination of serum albumin and cholinesterase levels as prognostic indicator in patients ith colorectal cancer. Anticancer Res. 2019;39(2):1085–1090. doi:10.21873/anticanres.1321730711999
   PubMed Web of Science ®Google Scholar
• Chen P, Wang C, Cheng B, et al. Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer. Onco Targets Ther. 2017;10:3107–3118. doi:10.2147/OTT.S13885428790844
   PubMed Web of Science ®Google Scholar
• He ZQ, Duan H, Ke C, et al. Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas. Oncotarget. 2017;8(30):49605–49614. doi:10.18632/oncotarget.1784928548947
   PubMedGoogle Scholar
• Matsuda S, Takeuchi H, Kawakubo H, et al. Prognostic impact of change in the fibrinogen and albumin score during preoperative treatment in esophageal cancer patients. World J Surg. 2017;41(11):2788–2795. doi:10.1007/s00268-017-4074-828608015
   PubMed Web of Science ®Google Scholar
• Cui J, Yu M, Zhang N, et al. Prognostic scores based on the preoperative plasma fibrinogen and serum albumin level as a prognostic factor in patients with upper urinary tract urothelial carcinoma. Oncotarget. 2017;8(40):68964–68973. doi:10.18632/oncotarget.1648328978171
   PubMedGoogle Scholar
• Ayhan A, Gunakan E, Alyazici I, Haberal N, Altundag O, Dursun P. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet. 2017;296(5):989–995. doi:10.1007/s00404-017-4511-928875365
   PubMed Web of Science ®Google Scholar
• Huang QT, Zhou L, Zeng WJ, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in ovarian cancer: a systematic review and meta-analysis of observational studies. Cell Physiol Biochem. 2017;41(6):2411–2418. doi:10.1159/00047591128467978
   PubMedGoogle Scholar
• Suszynska M, Klonowska K, Jasinska AJ, Kozlowski P. Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes – providing evidence of cancer predisposition genes. Gynecol Oncol. 2019. doi:10.1016/j.ygyno.2019.01.027
   PubMed Web of Science ®Google Scholar
• Beamer LC, Breast H. Hereditary ovarian cancer: implications for the oncology nurse. Semin Oncol Nurs. 2019;35(1):47–57. doi:10.1016/j.soncn.2018.12.00130711354
   PubMed Web of Science ®Google Scholar
• Vergote I. Role of surgery in ovarian cancer: an update. Acta Chir Belg. 2004;104(3):246–256.15285533
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Banerjee S, Kaye SB. New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential. Clin Cancer Res. 2013;19(5):961–968. doi:10.1158/1078-0432.CCR-12-224323307860
   PubMed Web of Science ®Google Scholar
• Wang S, Ma Y, Sun L, et al. Prognostic significance of pretreatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with diffuse large B-cell lymphoma. Biomed Res Int. 2018;2018:9651254. doi:10.1155/2018/965125430643825
   PubMed Web of Science ®Google Scholar
• Luo P, Cai W, Yang L, et al. Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection. Cancer Manag Res. 2018;10:4727–4734. doi:10.2147/CMAR.S17160230425569
   PubMed Web of Science ®Google Scholar
• Wei Y, Xu H, Dai J, et al. Prognostic significance of serum lactic acid, lactate dehydrogenase, and albumin levels in patients with metastatic colorectal cancer. Biomed Res Int. 2018;2018:1804086. doi:10.1155/2018/180408630627541
   PubMed Web of Science ®Google Scholar
• Song H, Kuang G, Zhang Z, Ma B, Jin J, Zhang Q. The prognostic value of pretreatment plasma fibrinogen in urological cancers: a systematic review and meta-analysis. Journal of Cancer. 2019;10(2):479–487. doi:10.7150/jca.2698930719143
   PubMed Web of Science ®Google Scholar
• Arthur R, Williams R, Garmo H, et al. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. Int J Cancer. 2018;142(11):2254–2262. doi:10.1002/ijc.3125629322512
   PubMed Web of Science ®Google Scholar
• Sun KY, Xu JB, Chen SL, et al. Novel immunological and nutritional-based prognostic index for gastric cancer. World J Gastroenterol. 2015;21(19):5961–5971. doi:10.3748/wjg.v21.i19.596126019461
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715–727. doi:10.1038/nri193616977338
   PubMed Web of Science ®Google Scholar
• Li W, Tang Y, Song Y, et al. Prognostic role of pretreatment plasma d-dimer in patients with solid tumors: a systematic review and meta-analysis. Cell Physiol Biochem. 2018;45(4):1663–1676. doi:10.1159/00048773429490291
   PubMedGoogle Scholar
• Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol. 2001;8(5):270–276.11604561
   PubMed Web of Science ®Google Scholar
• Qiu J, Yu Y, Fu Y, Ye F, Xie X, Lu W. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res. 2012;38(4):651–657. doi:10.1111/j.1447-0756.2011.01780.x22413879
   PubMed Web of Science ®Google Scholar
• Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res. 2002;62(23):6966–6972.12460914
   PubMed Web of Science ®Google Scholar
• Ataseven B, du Bois A, Reinthaller A, et al. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015;138(3):560–565. doi:10.1016/j.ygyno.2015.07.00526163893
   PubMed Web of Science ®Google Scholar
• Borg N, Guilfoyle MR, Greenberg DC, Watts C, Thomson S. Serum albumin and survival in glioblastoma multiforme. J Neurooncol. 2011;105(1):77–81. doi:10.1007/s11060-011-0562-021409514
   PubMed Web of Science ®Google Scholar